Press release

FDB Releases Expanded Canadian French Drug Knowledge

Sponsored by Businesswire

FDB (First Databank, Inc.), the leading provider of drug and medical
device knowledge that helps healthcare professionals make precise
decisions, today announced the release of FDB
MedKnowledge Canada
with additional
clinician-facing content in Canadian French to support bi-lingual app
development for the safe use of medications for a variety of healthcare
applications. With the French-speaking population across Canada estimated
at 21 percent of all Canadians and the province of Quebec at 95 percent,
the inclusion of Canadian French is a requirement to support National
health IT initiatives that use medication content within information
systems serving Quebec and other French speaking regions.

The expanded Canadian French content now encompasses drug dosing and
precautions modules covering geriatric and pediatric patients, as well
as those who are pregnant or lactating. It also covers drug-drug
interaction clinical screening with professional monographs that
encompass more in-depth details on drug interactions to provide
actionable information in the clinical workflow.

In 2016, FDB released Canadian French content for drug descriptive
information such as drug names, dose forms and routes; and clinical
decision support for drug-allergy and duplicate therapy screening. Now
with the expanded clinician-facing content, information system
developers will be able to program to a single database structure from
FDB to ensure consistency in functionality of health applications in
both English and French serving the Canadian market.

“For more than three decades, our Canadian customers have placed their
trust in FDB and the medication content we provide to support essential
health IT applications,” said Chuck Tuchinda, MD, MBA, president, FDB.
“With the additional clinical content we have now released in Canadian
French, we have expanded our commitment to serving our customers in this
market to ensure there are no limiting factors in creating bi-lingual
applications for optimal use of drugs across the healthcare spectrum.”

FDB MedKnowledge Canada is the healthcare industry’s most widely used
source of drug information utilized at the point of care. Encompassing
drugs and natural health products approved by Health Canada, it combines
descriptive drug information and unique identifiers with an extensive
array of clinical decision support modules. FDB MedKnowledge Canada
helps pharmacists, physicians, nurses and other medical professionals
avoid medication errors, prevent adverse drug events, reduce
drug-related expenses and improve the quality of patient care.

To learn more about these and other FDB solutions, visit our new Canadian
in both English and French,
and speak with the FDB staff in booth #43 at the upcoming eHealth
, May 26 – 29, 2019, in Toronto, ON.

About First Databank

FDB is the leading provider of drug and medical device knowledge that
helps healthcare professionals make precise decisions. With thousands of
customers worldwide, FDB enables our information system developer
partners to deliver valuable, useful, and differentiated solutions. We
offer more than four decades of experience in transforming medical
knowledge into actionable, targeted, and effective solutions that help
improve patient safety, operational efficiency, and healthcare outcomes.
For a complete look at our solutions and services, please visit
or follow us on Twitter,
and YouTube.

About Hearst Health

The mission of Hearst Health is to help guide the most important care
moments by delivering vital information into the hands of everyone who
touches a person’s health journey. Each year in the U.S., care guidance
from Hearst Health reaches 85 percent of discharged patients, 205
million insured individuals, 77 million home health visits and 3.2
billion dispensed prescriptions. The Hearst Health network includes FDB
(First Databank), Zynx
, MCG,
(formerly MedHOK—Medical House of Knowledge) and Hearst
Health Ventures
Hearst also holds a minority interest in the precision medicine and
oncology analytics company M2Gen.
Follow Hearst Health on Twitter @HearstHealth
or LinkedIn @Hearst-Health.

©2019 First Databank, Inc. Part of the Hearst Health network.
All trademarks mentioned herein are the properties of their respective